Morphological, molecular and clinical characterization of head and neck carcinoma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015825

Enrollment

500

Registered

2019-06-27

Start date

2018-10-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C14 C30 C31 C32

Interventions

Group 1: Malignancies of oral cavity, throat, larynx, salivary glands, nose and paranasal sinuses are summarized under head and neck cancer (HNC). In addition to the frequent squamous cell carcinoma,

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: Head and neck carcinoma (without intracraniell maligancies)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Effect of histopathologic markers on prognosis and outcome	—

Secondary

Measure	Time frame
Relations between histopathology and molecular markers	—

Countries

Germany

Contacts

Public ContactChristoph Becker

Universitätsklinikum Freiburg, Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie

christoph.becker@uniklinik-freiburg.de+4976127042010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026